Results 11 to 20 of about 2,100,798 (313)
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
Journal of gastroenterology, 2021 The first edition of the clinical practice guidelines for liver cirrhosis was published in 2010, and the second edition was published in 2015 by the Japanese Society of Gastroenterology (JSGE).
H. Yoshiji +20 more
semanticscholar +2 more sources
Nursing Standard, 2008 Cirrhosis is defined as the histological development of regenerative nodules surrounded by fibrous bands in response to chronic liver injury, which leads to portal hypertension and end-stage liver disease. Recent advances in the understanding of the natural history and pathophysiology of cirrhosis, and in treatment of its complications, have resulted ...
Detlef, Schuppan, Nezam H, Afdhal
openaire +4 more sources
Computed Tomography Images of Spontaneous Portosystemic Shunt in Liver Cirrhosis
Canadian Journal of Gastroenterology and Hepatology, 2022 Spontaneous portosystemic shunt (SPSS) refers to collateral vessels that communicate between the portal vein system and systemic circulation. SPSS mainly includes esophageal varices, gastric varices, left gastric vein, recanalized paraumbilical vein ...
Fangfang Yi +7 more
doaj +1 more source
World Journal of Gastroenterology, 2022 Cirrhosis causes a heavy global burden. In this review, we summarized up-to-date epidemiological features of cirrhosis and its complications. Recent epidemiological studies reported an increase in the prevalence of cirrhosis in 2017 compared to in 1990 ...
Yuanbin Liu, Mingkai Chen
semanticscholar +1 more source
Serum microRNA-122 predicts survival in patients with liver cirrhosis [PDF]
, 2012 Background: Liver cirrhosis is associated with high morbidity and mortality. MicroRNAs (miRs) circulating in the blood are an emerging new class of biomarkers.
Brunner, Friederike +5 more
core +8 more sources
Clinical and Applied Thrombosis/Hemostasis, 2021 Portal venous system thrombosis (PVST), a common complication of liver cirrhosis, is closely associated with thrombophilia. To explore the association of homocysteine (Hcy), anticardiolipin antibody (aCL), and anti-β2 glycoprotein I antibody (aβ 2 GPI ...
Le Wang +8 more
doaj +1 more source
Malnutrition in Patients with Liver Cirrhosis
Nutrients, 2021 Liver cirrhosis is an increasing public health threat worldwide. Malnutrition is a serious complication of cirrhosis and is associated with worse outcomes. With this review, we aim to describe the prevalence of malnutrition, pathophysiological mechanisms,
J. Traub +3 more
semanticscholar +1 more source
Identification of novel non-HFE mutations in Chinese patients with hereditary hemochromatosis
Orphanet Journal of Rare Diseases, 2022 Backgrounds Hereditary hemochromatosis (HH) is mainly caused by homozygous p.C282Y mutations in HFE in the Caucasians. We recently reported non-HFE mutations constitute the major cause of HH in Chinese.
Wei Zhang +17 more
doaj +1 more source
Irisin in Liver Cirrhosis [PDF]
Journal of Clinical Medicine, 2020 Background: Sarcopenia is a prevalent muscle abnormality characterized by progressive and generalized loss of skeletal muscle mass and strength, common among patients with decompensated advanced chronic liver disease (dACLD). Irisin is a recently identified myokine, which is mainly expressed and secreted by skeletal muscle.
Michał Kukla +11 more
openaire +3 more sources
Correlation of genotype and phenotype in 32 patients with hereditary hemochromatosis in China
Orphanet Journal of Rare Diseases, 2021 Background Hereditary hemochromatosis (HH) is widely recognized and clinical manifestations of hemochromatosis-related (HFE-related) HH is well studied in European populations.
Liyan Wu +17 more
doaj +1 more source